Heart Failure and Cardiomyopathies

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic BacNav Gene Therapy Improves Function of Infarcted Engineered Human Myocardium and NHPs There’s No Place Like Home: Using Ambulatory Invasive Hemodynamic Monitoring to Facilitate Early Discharge From Heart Failure Hospitalization Left Atrial Volumetric/Mechanical Coupling Index Is Ready for Prime Time Across Clinical Scenarios Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction Prevalence, Mechanisms, and Prognostic Impact of Effort Intolerance in Patients With Asymptomatic/Minimally Symptomatic Aortic Stenosis Pyruvate Dehydrogenase Kinase 4 Underlies the Metabolic Disorder of Cardiomyocytes in Patients With Hypertrophic Cardiomyopathy From Hypertrophy to Heart Failure Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA‐MI Trial Size Matters. Prevalence and Clinical Implications of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy: A Systematic Review and Meta‐Analysis